Quest Diagnostics (NYSE:DGX) Raised to Buy at StockNews.com

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning. Other equities research analysts also recently issued reports about the stock. Citigroup boosted their target price on shares of Quest Diagnostics from $130.00 to $145.00 and gave the stock a […]

Related Keywords

United States ,American ,America ,Piper Sandler ,Barclays ,Citigroup ,Pricet Rowe Associates Inc ,Jpmorgan Chase Co ,Quest Diagnostics Incorporated ,American Century Companies Inc ,Quest Diagnostics Company Profile ,Norges Bank ,Vanguard Group Inc ,Quest Diagnostics ,Free Report ,Get Free Report ,American Century Companies ,Century Companies ,Diagnostics Incorporated ,Quest Diagnostics Daily ,Nyse Dgx ,Dgx ,Medical ,74834l10 ,Upgrade ,Stocknews Com ,